metaPreg - Lofepramine during pregnancy

Lofepramine updated on 10-20-2025

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. exposed	publication bias	ROB	E-value
Neuro-developmental disorders
ADHD (Attention deficit hyperactivity disorder): Diagnosis	1.74 [0.82, 3.68]	-	1 study	296	not evaluable	ROB	-
ADHD (Attention deficit hyperactivity disorder): Diagnosis/Risk	1.74 [0.82, 3.68]	-	1 study	296	not evaluable	ROB	-
ASD (Autism spectrum disorder): Diagnosis	2.52 [1.23, 5.17]	-	1 study	296	not evaluable	ROB	4.48 [1.76; .]
ASD (Autism spectrum disorder): Diagnosis/Risk	2.52 [1.23, 5.17]	-	1 study	296	not evaluable	ROB	4.48 [1.76; .]
Cognitive developmental disorders/delay (> 6 years old)	1.88 [0.72, 4.88]	-	1 study	296	not evaluable	ROB	-
Severe cognitive developmental delay (Mental retardation) (> 6 years old)	1.88 [0.72, 4.88]	-	1 study	296	not evaluable	ROB	-
Hide endpoints reported in only one study ...